Allan M. Fox, Director at REGENXBIO Inc. (RGNX), sold 225,738 shares at $35.85 ($7.8M) on 2021-12-23, disclosed to the SEC on 2021-12-27.
Open-market sale of $7.8M RGNX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.40 | 61,638 | $2.1M | 27.1% |
| 2 | $34.40 | 61,638 | $2.1M | 27.1% |
| 3 | $34.92 | 44,908 | $1.6M | 20.0% |
| 4 | $34.92 | 44,908 | $1.6M | 20.0% |
| 5 | $35.85 | 6,323 | $227K | 2.9% |
| 6 | $35.85 | 6,323 |
| $227K |
| 2.9% |
| Total | $34.69 avg | 225,738 | $7.8M | 100% |